Ron has spent over 30 years in the international pharmaceutical industry, including roles as President of International Operations at Searle and Vice President of Clinical and Scientific Affairs at Pfizer. Ron’s extensive experience includes leading companies as Chief Executive and acting as an adviser to companies in the pharmaceutical industry. Ron also advises companies involved in nanotechnology and in the information technology business sectors.   Ron was formerly President and Chief Executive of Unimed Pharmaceuticals, Inc. and eXegenics Inc. Ron was a Trustee of Thunderbird School of Global Management, which was ranked by the Financial Times as the premier international business school.   Ron has a PhD from the University of Georgia and a MS and BS from the University of Memphis. He is a recipient of the University of Georgia distinguished alumni award.   Other appointments:   Ron is the Chairman of The Goode Group, advisers to the pharmaceutical industry, a Director of Mercy Ships International, a medical services charity, and a Senior Business Advisor to The Kinsella Group, an investment banking company. Additionally he is a member of Private Access, Inc., a medical record software developer.   Committee membership: Audit Committee CRE Committee (Chair until May 2017) Remuneration Committee

 Finance